Poly-ε-caprolactone tungsten oxide nanoparticles as a contrast agent for X-ray computed tomography

Biomaterials

Volumn 35, Issue 9, 2014, Pages 2981-2986

  Jakhmola, Anshuman ^a,b   Anton, Nicolas ^a,b   Anton, Halina ^a,c   Messaddeq, Nadia ^d   Hallouard, François ^e,f   Klymchenko, Andrey ^a,c   Mely, Yves ^a,c   Vandamme, Thierry F ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Faculté de Pharmacie   (France)

^c Faculté de Pharmacie   (France)

^d INSERM   (France)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

Contrast agent; Micro CT; Nanoparticles; Preclinical imaging; Tungsten oxide; X ray imaging

Indexed keywords

CONTRAST AGENT; MICRO-CT; NANOPARTICLES; PRECLINICAL IMAGING; TUNGSTEN OXIDE; X-RAY IMAGING;

ANIMALS; CELL DEATH; CONTRAST MEDIA; HELA CELLS; HUMANS; HYDRODYNAMICS; MICE; NANOPARTICLES; OXIDES; PARTICLE SIZE; POLYESTERS; TOMOGRAPHY, X-RAY COMPUTED; TUNGSTEN; X-RAY MICROTOMOGRAPHY; X-RAYS;

EID: 84894911692     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.032     Document Type: Article

References (38)

1. Anton N., Vandamme T.F. Nanotechnology for computed tomography: a real potential recently disclosed. Pharm Res 2014, 31:20-34.
2. Hallouard F., Anton N., Choquet P., Constantinesco A., Vandamme T.F. Iodinated blood pool contrast media for preclinical X-ray imaging applications - a review. Biomaterials 2010, 24:6249-6268.
3. Lee N., Choi S.H., Hyeon T. Nano-sized CT contrast agents. Adv Mater 2013, 25:2641-2660.
4. Jakhmola A., Anton N., Vandamme T.F. Inorganic nanoparticles based contrast agents for X-ray computed tomography. Adv Healthc Mater 2012, 1:413-431.
5. Liu Y., Ai K., Lu L. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications. Acc Chem Res 2012, 45:1817-1827.
6. Yu S., Watson A. Metal-based X-ray contrast media. Chem Rev 1999, 99:2353-2378.
7. Au J.T., Craig G., Longo V., Zanzonico P., Mason M., Fong Y., et al. Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging. Am J Roentgenol 2013, 200:1347-1351.
8. Cai Q.Y., Kim S.H., Choi K.S., Kim S.Y., Byun S.J., Kim K.W., et al. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest Radiol 2007, 42:797-806.
9. Chien C.C., Chen H.H., Lai S.F., Hwu Y., Petibois C., Yang C.S., et al. X-ray imaging of tumor growth in live mice by detecting gold-nanoparticle-loaded cells. Sci Rep 2012, 2:610-616.
10. Eck W., Nicholson A., Zentgraf H., Semmler W., Bartling S. Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. Nano Lett 2010, 10:2318-2322.
11. Kojima C., Umeda Y., Ogawa M., Harada A., Magata Y., Kono K. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer. Nanotechnology 2010, 21:245104-245109.
12. Liu H., Wang H., Guo R., Cao X., Zhao J., Luo Y., et al. Size-controlled synthesis of dendrimer-stabilized silver nanoparticles for X-ray computed tomography imaging applications. Polym Chem 2010, 1:1677-1683.
13. Dekrafft K.E., Boylen W.S., Burk L.M., Zhou O.Z., Lin W. Zr- and Hf-based nanoscale metal-organic frameworks as contrast agents for computed tomography. J Mater Chem 2012, 22:18139-18144.
14. Liu F., He X., Liu L., You H., Zhang H., Wang Z. Conjugation of NaGdF4 up converting nanoparticles on silica nanospheres as contrast agents for multi-modality imaging. Biomaterials 2013, 34:5218-5225.
15. Liu Y., Ai K., Liu J., Yuan Q., He Y., Lu L. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew Chem Int Ed Engl 2012, 51:1437-1442.
16. Xing H., Bu W., Zhang S., Zheng X., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
17. Bonitatibus P.J.J., Torres A.S., Goddard G.D., Fitz G.P.F., Kulkarni A.M. Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agent. Chem Commun 2010, 46:8956-8958.
18. Bonitatibus P.J.J., Torres A.S., Kandapallil B., Lee B.D., Goddard G.D., Colborn R.E., et al. Preclinical assessment of a zwitterionic tantalum oxide nanoparticle X-ray contrast agent. ACS Nano 2012, 6:6650-6658.
19. Oh M.H., Lee N., Kim H., Park S.P., Piao Y., Lee J., et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc 2011, 133:5508-5515.
20. Brown A.L., Goforth A.M. pH-dependent synthesis and stability of aqueous, elemental bismuth glyconanoparticle colloids: potentially biocompatible X-ray contrast agents. Chem Mater 2012, 24:1599-1605.
21. Fang Y., Peng C., Guo R., Zheng L., Qin J., Zhou B., et al. Dendrimer-stabilized bismuth sulfide nanoparticles: synthesis, characterization, and potential computed tomography imaging applications. Analyst 2013, 138:3172-3180.
22. Pan D., Roessl E., Schlomka J.P., Caruthers S.D., Senpan A., Scott M.J., et al. Computed tomography in color: NanoK-enhanced spectral CT molecular imaging. Angew Chem Int Ed Engl 2010, 49:9635-9639.
23. Rabin O., Perez M.J., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006, 5:118-122.
24. Dong W., Li Y., Niu D., Ma Z., Liu X., Gu J., et al. A simple route to prepare monodisperse Au NP-decorated, dye-doped, superparamagnetic nanocomposites for optical, MR, and CT trimodal imaging. Small 2013, 9:2500-2508.
25. Hayashi K., Nakamura M., Miki H., Ozaki S., Abe M., Matsumoto T., et al. Gold nanoparticle cluster-plasmon-enhanced fluorescent silica core-shell nanoparticles for X-ray computedtomography-fluorescence dual-mode imaging of tumors. Chem Commun 2013, 49:5334-5336.
26. Lee N., Cho H.R., Oh M.H., Lee S.H., Kim K., Kim B.H., et al. Multifunctional Fe3O4/TaO(x) core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. J Am Chem Soc 2012, 134:10309-10312.
27. Alkilany A.M., Murphy C.J. Toxicity and cellular uptake of gold nanoparticles: what we have learned so farα. J Nanopart Res 2010, 12:2313-2333.
28. Goodman C.M., McCusker C.D., Yilmaz T., Rotello V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 2004, 15:897-900.
29. Maitin S. Nanotoxicity of gold and iron nanoparticles. J Biomed Nanotechnol 2011, 7:65.
30. Hille R. Molybdenum and tungsten in biology. Trends Biochem Sci 2002, 27:360-367.
31. Kletzin A., Adams M.W.W. Tungsten in biological systems. FEMS Microbiol Rev 1996, 18:5-63.
32. Niederberger M., Bartl M.H., Stucky G.D. Benzyl alcohol and transition metal chlorides as a versatile reaction system for the nonaqueous and low-temperature synthesis of crystalline nano-objects with controlled dimensionality. J Am Chem Soc 2002, 124:13642-13643.
33. Polleux J., Antonietti M., Niederberger M. Ligand and solvent effects in the nonaqueous synthesis of highly ordered anisotropic tungsten oxide nanostructures. J Mater Chem 2006, 16:3969-3975.
34. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006, 79:248-253.
35. Xu C., Tung G.A., Sun S. Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem Mater 2008, 20:4167-4169.
36. Zhang A., Tu Y., Qin S., Li Y., Zhou J., Chen N., et al. Gold nanoclusters as contrast a gents for fluorescent and X-ray dual-modality imaging. J Colloid Interface Sci 2012, 372:239-244.
37. Li X., Anton N., Zuber G., Zhao M., Messaddeq N., Hallouard F., et al. Iodinated α-tocopherol nano-emulsions as non-toxic contrast agents for preclinical X-ray imaging. Biomaterials 2013, 34:481-491.
38. Hallouard F., Briançon S., Anton N., Li X., Vandamme T.F., Fessi H. Poly(ethylene glycol)-poly(ε-caprolactone) iodinated nanocapsules as contrast agents for X-ray imaging. Pharm Res 2013, 30:2023-2035.